Page 5 - Sight Sciences News Today

Item 2.05 Costs Associated with Exit or Disposal Activities On October 17, 2023, Sight Sciences, Inc. informed its employees that it is implementing a targeted...

Silk Road Medical (Nasdaq:SILK) today announced that CEO Erica Rogers plans to retire from the company once a successor is named.

Sight Sciences, Inc. announced the results of the large scale, comparative real-world clinical outcomes study of patients treated by three leading minimally invasive glaucoma surgery technologies,...

Sight Sciences, Inc. (NASDAQ:SGHT – Get Free Report) was the recipient of a large increase in short interest in September. As of September 15th, there was short interest totalling 710,900 shares, an increase of 41.8% from the August 31st total of 501,200 shares. Based on an average daily volume of 196,300 shares, the short-interest ratio […]

Sight Sciences, Inc. (NASDAQ:SGHT – Get Free Report) was the recipient of a significant increase in short interest during the month of September. As of September 15th, there was short interest totalling 710,900 shares, an increase of 41.8% from the August 31st total of 501,200 shares. Based on an average daily volume of 196,300 shares, […]

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Bank of America cut shares of Sight Sciences (NASDAQ:SGHT – Free Report) from a neutral rating to an underperform rating in a research note issued to investors on Tuesday morning, Marketbeat Ratings reports. Bank of America currently has $4.50 target price on the stock, down from their prior target price of $10.00. Other research analysts […]

Analysts’ updated eps estimates for Monday, September 11th: Autodesk (NASDAQ:ADSK) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating. Barclays (NYSE:BCS) was downgraded by analysts at StockNews.com from a buy rating to a hold rating. Macquarie began coverage on shares of BeiGene (NASDAQ:BGNE). The firm issued an outperform rating on […]

Sight Sciences (NASDAQ:SGHT – Get Free Report) was downgraded by analysts at Piper Sandler from an “overweight” rating to a “neutral” rating in a research note issued to investors on Monday, FlyOnTheWall reports. Other analysts have also issued reports about the stock. Citigroup cut their target price on Sight Sciences from $9.00 to $8.00 and […]